Different sources of autologous mononuclear cells and stem cells for critical lower limb ischaemia

  • Protocol
  • Intervention

Authors

  • S Fadilah Abdul Wahid,

    Corresponding author
    1. Universiti Kebangsaan Malaysia Medical Centre, Cell Therapy Center, Kuala Lumpur, Malaysia
    2. Universiti Kebangsaan Malaysia Medical Centre, Clinical Haematology & Stem Cell Transplantation Services, Department of Medicine, Kuala Lumpur, Malaysia
    • S Fadilah Abdul Wahid, Cell Therapy Center, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Kuala Lumpur, 56000, Malaysia. sfadilah@ppukm.ukm.edu.my.

    Search for more papers by this author
  • Nor Azimah Ismail,

    1. Universiti Kebangsaan Malaysia Medical Centre, Cell Therapy Center, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Muhammad Khairul Azaham Abdul Hamid,

    1. Universiti Kebangsaan Malaysia Medical Centre, Cell Therapy Center, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Hanafiah Harunarashid,

    1. Universiti Kebangsaan Malaysia Medical Centre, Unit of Vascular Surgery, Department of Surgery, Kuala Lumpur, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Muhamad Azim Mohd Idris,

    1. Universiti Kebangsaan Malaysia Medical Centre, Unit of Vascular Surgery, Department of Surgery, Kuala Lumpur, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Nor Asiah Muhamad,

    1. Institute for Medical Research, Medical Research Resource Centre, Kuala Lumpur, Malaysia
    Search for more papers by this author
  • Nai Ming Lai

    1. University of Malaya Medical Center, Department of Paediatrics, Paediatric and Child Health Research Group, Kuala Lumpur, Malaysia
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of autologous mononuclear cells (MNCs) and stem cells derived from different sources in patients with critical lower limb ischaemia (CLI).